Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 521,917 | 542,513 | 869,191 | 632,953 | 565,119 |
| Marketable Securities | 1,499,910 | 1,509,880 | 1,245,782 | 1,354,146 | 1,494,151 |
| Receivables | 6,751 | 26,122 | 61,896 | 9,068 | 24,004 |
| Inventories | 19,811 | 24,032 | 24,806 | 22,930 | 24,099 |
| Other current assets | 142,759 | 150,577 | 143,374 | 136,643 | 131,045 |
| TOTAL | $2,191,148 | $2,253,124 | $2,345,049 | $2,155,740 | $2,238,418 |
| Non-Current Assets | |||||
| PPE Net | 177,015 | 177,724 | 178,069 | 180,144 | 179,316 |
| Intangibles | 29,054 | 29,295 | 0 | 30,038 | 29,373 |
| Other Non-Current Assets | 58,916 | 58,949 | 88,572 | 48,971 | 49,962 |
| TOTAL | $264,985 | $265,968 | $266,641 | $259,153 | $258,651 |
| Total Assets | $2,456,133 | $2,519,092 | $2,611,690 | $2,414,893 | $2,497,069 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,732 | 4,206 | N/A | 65,045 | 69,848 |
| Accounts payable and accrued liabilities | 10,351 | 16,125 | 11,904 | 8,357 | 14,658 |
| Accrued Expenses | 159,321 | 115,781 | 127,370 | 108,001 | 105,372 |
| Other current liabilities | N/A | N/A | 3,526 | N/A | N/A |
| TOTAL | $267,811 | $228,450 | $240,550 | $279,778 | $293,825 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,093 | 25,710 | 6,946 | 21,628 | 22,055 |
| Deferred Revenues | 93,393 | 91,437 | 97,714 | 97,925 | 102,072 |
| Other Non-Current Liabilities | 1,223,307 | 1,222,220 | 1,240,578 | 1,220,064 | 1,218,641 |
| TOTAL | $1,563,596 | $1,581,068 | $1,599,403 | $1,604,579 | $1,620,570 |
| Total Liabilities | $1,831,407 | $1,809,518 | $1,839,953 | $1,884,357 | $1,914,395 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 141,941 | 141,798 | 141,689 | 141,210 | 141,148 |
| Common Shares | 142 | 142 | 141 | 141 | 141 |
| Retained earnings | -1,330,203 | -1,225,068 | -1,159,903 | -1,384,516 | -1,302,050 |
| Other shareholders' equity | -54,007 | -48,578 | -32,668 | -27,437 | -25,796 |
| TOTAL | $624,726 | $709,574 | $771,737 | $530,536 | $582,674 |
| Total Liabilities And Equity | $2,456,133 | $2,519,092 | $2,611,690 | $2,414,893 | $2,497,069 |